Angiotensin II receptor blockade reduces salt sensitivity of blood pressure through restoration of renal nitric oxide synthesis in patients with diabetic nephropathy

JRAAS - Journal of the Renin-Angiotensin-Aldosterone System

Volumn 14, Issue 1, 2013, Pages 67-73

  Imanishi, Masahito ^a   Okada, Noriyuki ^a   Konishi, Yoshio ^a   Morikawa, Takashi ^a   Maeda, Isseki ^a   Kitabayashi, Chizuko ^a   Masada, Masahiro ^b   Shirahashi, Nobuo ^c   Wilcox, Christopher S ^d   Nishiyama, Akira ^e  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b CHIBA UNIVERSITY   (Japan)

^c OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^d GEORGETOWN UNIVERSITY   (United States)

^e KAGAWA UNIVERSITY   (Japan)

Author keywords

Angiotensin II receptor blocker (ARB); diabetic nephropathy; nitric oxide; oxidative stress; salt

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; ANGIOTENSIN RECEPTOR; CREATININE; GLUCOSE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SODIUM CHLORIDE; TETRAHYDROBIOPTERIN; VALSARTAN;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETIC NEPHROPATHY; DIASTOLIC BLOOD PRESSURE; DRUG MECHANISM; FEMALE; GLUCOSE BLOOD LEVEL; HIGH SODIUM INTAKE; HUMAN; MALE; MEAN ARTERIAL PRESSURE; MICROALBUMINURIA; NATRIURESIS; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; SODIUM EXCRETION; SODIUM RESTRICTION; SYSTOLIC BLOOD PRESSURE; URINARY EXCRETION;

ALBUMINURIA; ANGIOTENSIN RECEPTOR ANTAGONISTS; BIOPTERIN; BLOOD PRESSURE; DEOXYGUANOSINE; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMODYNAMICS; HUMANS; KIDNEY; MALE; MIDDLE AGED; NITRATES; NITRIC OXIDE; NITRITES; RECEPTORS, ANGIOTENSIN; SODIUM CHLORIDE, DIETARY; TETRAZOLES; VALINE;

EID: 84874096223     PISSN: 14703203     EISSN: 17528976     Source Type: Journal    
DOI: 10.1177/1470320312454764     Document Type: Article

References (27)

1. Johnson RJ, Herrera-Acosta J, Schreiner GF, et al. Subtle acquired renal injury as a mechanism of salt-sensitive hypertension. N Engl J Med. 2002 ; 346: 913-923
2. Evans RG, Majid DS, Eppel GA. Mechanisms mediating pressure natriuresis: What we know and what we need to find out. Clin Exp Pharmacol Physiol. 2005 ; 32: 400-409
3. Klahr S. The role of nitric oxide in hypertension and renal disease progression. Nephrol Dial Transplant. 2001 ; 16: 60-62
4. Erdely A, Freshour G, Maddox DA, et al. Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production. Diabetologia. 2004 ; 47: 1672-1676
5. Manning RD, Hu L, Tan DY, et al. Role of abnormal nitric oxide systems in salt-sensitive hypertension. Am J Hypertens. 2001 ; 14: 68S - 73S
6. Earle KA, Mehrotra S, Dalton RN, et al. Defective nitric oxide production and functional renal reserve in patients with type 2 diabetes who have microalbuminuria of African and Asian compared with white origin. J Am Soc Nephrol. 2001 ; 12: 2125-2130
7. Konishi Y, Morikawa T, Yasu T, et al. Blunted response of the renin-angiotensin system and nitric oxide synthesis related to sodium sensitivity in immunoglobulin a nephropathy. Hypertens Res. 2004 ; 27: 7-13
8. Matsuda H, Hayashi K, Homma K, et al. Differing anti-proteinuric action of candesartan and losartan in chronic renal disease. Hypertens Res. 2003 ; 26: 875-880
9. Imanishi M, Yoshioka K, Okumura M, et al. Sodium sensitivity related to albuminuria appearing before hypertension in type 2 diabetic patients. Diabetes Care. 2001 ; 24: 111-116
10. Morimoto A, Uzu T, Fujii T, et al. Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet. 1997 ; 350: 1734-1737
11. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997 ; 20: 1183-1197
12. Kimura G, Brenner BM Hypertension: Pathophysiology, diagnosis and management. The renal basis for salt sensitivity in hypertension. In: Laragh JH Brenner BM, ed. New York: Raven Press ; 1995: 1569-1588.
13. Shinozaki K, Hirayama A, Nishio Y, et al. Coronary endothelial dysfunction in the insulin-resistant state is linked to abnormal pteridine metabolism and vascular oxidative stress. J Am Coll Cardiol. 2001 ; 38: 1821-1828
14. Wilcox CS, Aminoff MJ, Slater JD. Sodium homeostasis in patients with autonomic failure. Clin Sci Mol Med. 1977 ; 53: 321-328
15. Majid DS, Said KE, Omoro SA, et al. Nitric oxide dependency of arterial pressure-induced changes in renal interstitial hydrostatic pressure in dogs. Circ Res. 2001 ; 88: 347-351
16. Patel AR, Granger JP, Kirchner KA. L-arginine improves transmission of perfusion pressure to the renal interstitium in Dahl salt-sensitive rats. Am J Physiol. 1994 ; 266: R1730 - R1735
17. Nagai Y, Yao L, Kobori H, et al. Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol. 2005 ; 16: 703-711
18. Onozato ML, Tojo A, Goto A, et al. Oxidative stress and nitric oxide synthase in rat diabetic nephropathy: Effects of ACEI and ARB. Kidney Int. 2002 ; 61: 186-194
19. Asaba K, Tojo A, Onozato ML, et al. Effects of NADPH oxidase inhibitor in diabetic nephropathy. Kidney Int. 2005 ; 67: 1890-1898
20. Ogawa S, Mori T, Nako K, et al. Angiotensin II type 1 receptor blockers reduce urinary oxidative stress markers in hypertensive diabetic nephropathy. Hypertension. 2006 ; 47: 699-705
21. Katusic ZS. Vascular endothelial dysfunction: Does tetrahydrobiopterin play a role?. Am J Physiol Heart Circ Physiol. 2001 ; 281: H981 - H986
22. Vasquez-Vivar J, Kalyanaraman B, Martasek P, et al. Superoxide generation by endothelial nitric oxide synthase: The influence of cofactors. Proc Natl Acad Sci U S A. 1998 ; 95: 9220-9225
23. Okumura M, Masada M, Yoshida Y, et al. Decrease in tetrahydrobiopterin as a possible cause of nephropathy in type II diabetic rats. Kidney Int. 2006 ; 70: 471-476
24. Heitzer T, Krohn K, Albers S, et al. Tetrahydrobiopterin improves endothelium-dependent vasodilation by increasing nitric oxide activity in patients with type II diabetes mellitus. Diabetologia. 2000 ; 43: 1435-1438
25. Fukuda M, Yamanaka T, Mizuno M, et al. Angiotensin II type 1 receptor blocker, olmesartan, restores nocturnal blood pressure decline by enhancing daytime natriuresis. J Hypertens. 2008 ; 26: 583-588
26. Song MF, Li YS, Ootsuyama Y, et al. Urea, the most abundant component in urine, cross-reacts with a commercial 8-OH-dG ELISA kit and contributes to overestimation of urinary 8-OH-dG. Free Radic Biol Med. 2009 ; 47: 41-46
27. Weinberger MH, Fineberg NS, Fineberg SE, et al. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001 ; 37: 429-432